H.R. 5343 · 115th Congress
Prescription Transparency Act of 2018
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
CarterSponsor38 cosponsors · 4 D, 34 R
R
Collins
HG
R
Griffith
CM
R
McMorris Rodgers
AS
R
Scott
PW
D
Welch
SD
R
DesJarlais
WJ
R
Jones
SK
R
King
DL
R
LaMalfa
PR
R
Roe
JF
R
Fortenberry
VG
D
Gonzalez
ES
R
Stefanik
RA
R
Allen
RC
R
Crawford
BF
D
Foster
PS
R
Sessions
JH
R
Hice
KC
R
Calvert
JC
R
Comer
GG
R
Graves
GG
R
Gianforte
BW
R
Westerman
KC
R
Cramer
AH
R
Harris
DB
R
Black
ND
R
Dunn
RM
R
Marshall
RA
R
Abraham
JC
D
Courtney
TG
R
Graves
DM
R
McKinley
CC
R
Collins
BG
R
Gibbs
WH
R
Hurd
MJ
R
Johnson
BP
R
Posey
BB
R
Babin5 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill prohibits contract provisions between a health insurer and a pharmacy that prohibit or penalize a pharmacist's disclosure to an individual purchasing a prescription drug of information regarding (1) the cost of the drug, (2) the availability of any therapeutically equivalent alternative drug, or (3) less expensive methods of purchasing the drug.
What it does: CRS summary · Introduced in House · Mar 20, 2018
Prescription Transparency Act of 2018
This bill prohibits contract provisions between a health insurer and a pharmacy that prohibit or penalize a pharmacist's disclosure to an individual purchasing a prescription drug of information regarding (1) the cost of the drug, (2) the availability of any therapeutically equivalent alternative drug, or (3) less expensive methods of purchasing the drug.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Prescription Transparency Act of 2018
Latest action (Mar 23, 2018): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Mar 20, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.